Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RFL | US
0
0%
Healthcare
Biotechnology
30/04/2024
09/03/2026
1.49
1.57
1.57
1.47
Rafael Holdings Inc. holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets in the United States and Israel. It operates in two segments Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat) that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings Inc. was incorporated in 2017 and is headquartered in Newark New Jersey.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
69.2%1 month
56.3%3 months
66.0%6 months
61.2%-
-
0.56
0.03
0.02
5.39
4.15
-
-70.22M
36.78M
36.78M
-
-18.41K
-
373.20
-63.51
1.84
0.43
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.40
Range1M
0.44
Range3M
0.48
Rel. volume
1.82
Price X volume
261.77K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | ATRA | Biotechnology | 6.68 | 38.52M | 29.21% | n/a | -81.03% |
| Galecto Inc | GLTO | Biotechnology | 28.69 | 37.61M | -0.76% | n/a | 0.33% |
| Tenax Therapeutics Inc | TENX | Biotechnology | 11.02 | 37.57M | 3.09% | n/a | 3.14% |
| Actinium Pharmaceuticals Inc | ATNM | Biotechnology | 1.2 | 37.39M | 0.00% | n/a | 4.22% |
| SABS | SABS | Biotechnology | 3.84 | 35.44M | 1.32% | n/a | 11.58% |
| Mustang Bio Inc | MBIO | Biotechnology | 0.9191 | 34.22M | 2.54% | n/a | -13.03% |
| QNRX | QNRX | Biotechnology | 8.43 | 33.55M | -2.77% | n/a | 43.11% |
| Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 0.7327 | 32.02M | 15.95% | n/a | 35.26% |
| Acurx Pharmaceuticals Inc. Common Stock | ACXP | Biotechnology | 1.955 | 31.76M | 44.81% | n/a | 0.00% |
| Alterity Therapeutics Limited | ATHE | Biotechnology | 3.55 | 31.04M | 3.50% | n/a | 1.15% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.23 | 32.59M | 0.90% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6001 | 11.60M | -5.42% | n/a | 58.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 3.98 | 6.06M | -4.33% | n/a | 204.46% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.47 | 3.75M | -0.67% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.39 | 3.71M | -1.76% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.46 | 1.36M | 2.93% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.008 | 737.72K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.39 | 0.53 | Expensive |
| Ent. to Revenue | 4.15 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.56 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 66.00 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 36.78M | 3.66B | Emerging |